94
Participants
Start Date
June 1, 2025
Primary Completion Date
March 2, 2027
Study Completion Date
May 30, 2027
lidocaine infusion
The lidocaine group will receive initial intravenous bolus dose of 1.5mg/kg lidocaine over 10 min, followed by a continuous infusion of 1.5 mg/kg/h lidocaine until the end of surgery. The dose of lidocaine will be calculated according to ideal body weight. The placebo group will be administered normal saline at the same volume, infusion rate and timing.
Placebo
The placebo group will be administered normal saline 0.9% at the same volume, infusion rate and timing as lidocaine in the lidocaine group
Medical University of Warsaw
OTHER